Esomeprazole Magnesium Granule, For Suspension, Extended Release
Product Images NDC 69097-527

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69097-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 01

Chemical structure of esomeprazole magnesium, showing its molecular formula including magnesium ions and hydration (2H2O). The diagram illustrates the arrangement of atoms and bonds within the esomeprazole magnesium molecule.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 02

A line graph showing the percentage maintained over a 6-month period for esomeprazole magnesium at 40 mg, 20 mg, 10 mg doses, and placebo. The y-axis indicates percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6. Different line styles represent each dose and placebo, illustrating their comparative performance over time.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 03

A line graph showing the percentage maintained over a 6-month period for esomeprazole magnesium at doses of 40 mg, 20 mg, and 10 mg, compared to a placebo. The x-axis represents months, and the y-axis represents the percent maintained. Higher doses (40 mg and 20 mg) show higher maintenance percentages over time compared to lower dose (10 mg) and placebo.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 04

A line chart displaying the percent of patients symptom-free over 28 days for three groups: Esomeprazole magnesium 40 mg, Esomeprazole magnesium 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent symptom-free from 0 to 100, illustrating symptom relief trends over time for each treatment group.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 05

A line graph showing the percentage of patients symptom-free over diary days for three groups: Esomeprazole magnesium 40 mg, Esomeprazole magnesium 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent of patients symptom-free from 0 to 100%. The graph indicates symptom improvement trends over time for each group.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 06

Label for Esomeprazole Magnesium 10 mg granule for oral suspension, extended-release, by Cipla USA Inc. The label includes usage instructions, dosage details, a pharmacist medication guide note, and identifies the product as Rx only. The NDC number 69097-527-34 is shown along with a barcode and storage conditions.*

FDA Label Image

373f3eb8 0c2c 4b99 9178 3baa6be7bd8d 07

The image shows the carton label for Esomeprazole Magnesium 10 mg extended-release granules for suspension, oral use, manufactured by Cipla USA Inc. The label states "for Delayed-Release Oral Suspension" and indicates the carton contains 30 child-resistant single-dose packets. The front panel prominently displays the drug name, strength, and a statement for pharmacists to dispense the enclosed medication guide. Additional labeling includes storage information and barcode on the side panel, with manufacturer details and a Cipla logo on the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.